Pulse Oximetry Devices Market

Valued at approximately $1.5bn, the pulse oximetry devices market serves a very important need in continuously monitoring acute care patients in hospitals as well as chronic, long-term care patients in alternate site facilities or remote home settings to prevent patient deterioration and death. The market is led by a handful of leading pulse oximetry device manufacturers, notably, Medtronic and Masimo, which are continuing to introduce next-generation products and benefiting from good, stable growth in the US as well as ever-increasing growth in underpenetrated international markets.